p47phox-Nox2-dependent ROS Signaling Inhibits Early Bone Development in Mice but Protects against Skeletal Aging

Jin-Ran Chen1, Oxana P Lazarenko2, Michael L Blackburn2

  • 1From the Arkansas Children's Nutrition Center and the Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72202 chenjinran@uams.edu.

Insights

Reduced reactive oxygen species (ROS) signaling in p47(phox-/-) mice leads to age-related bone loss. This occurs through increased inflammation and senescence, indicating ROS signaling suppresses aging-related bone inflammation.

Area of Science:

  • Bone Biology
  • Aging Research
  • Inflammation

Background:

  • Bone remodeling is tightly regulated by age, with aging often associated with increased reactive oxygen species (ROS).
  • The role of reduced ROS signaling in bone inflammation and remodeling during aging remains largely unexplored.
  • The p47(phox) protein is a crucial component of the Nox2 oxidase complex, essential for ROS production.

Purpose of the Study:

  • To investigate the impact of impaired Nox2 function (loss of p47(phox)) on bone metabolism and aging.
  • To elucidate the mechanisms by which reduced ROS signaling affects bone remodeling, inflammation, and senescence.
  • To determine if physiological ROS signaling plays a protective role against age-related bone changes.

Main Methods:

  • Utilized p47(phox) knock-out (p47(phox-/-)) mice and age-matched wild-type controls.
  • Assessed bone mass and strength at 6 weeks and 2 years of age.
  • Analyzed ROS generation, p47(phox)-Nox2 signaling, senescence-associated secretory phenotype, and inflammation in vivo and in ex vivo cell cultures.

Main Results:

  • p47(phox-/-) mice exhibited an age-related switch in bone mass and strength compared to controls.
  • Younger p47(phox-/-) mice showed increased bone formation, while older mice displayed decreased bone mass.
  • Older p47(phox-/-) mice had increased senescence and inflammation in bone, despite reduced ROS generation.

Conclusions:

  • The age-related decline in bone mass in p47(phox)-deficient mice is driven by an exacerbated inflammatory environment.
  • Physiological ROS signaling mediated by p47(phox)-Nox2 is critical for suppressing inflammation during aging.
  • Impaired ROS production contributes to accelerated bone senescence and inflammation, highlighting a protective role of ROS in bone aging.

Related Concept Videos

Bone Remodeling and Repair01:31

Bone Remodeling and Repair

10.7K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.9K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.7K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
41.3K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
15.7K